Microparticles mediate hepatic ischemia-reperfusion injury and are the targets of Diannexin (ASP8597)

N. Teoh, H.H. Ajamieh, H. Wong, Kevin Croft, Trevor Mori, A.C. Allison, G.C. Farrell

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)


Background & Aims: Ischemia-reperfusion injury (IRI) can cause hepatic failure after liver surgery or transplantation. IRI causes oxidative stress, which injures sinusoidal endothelial cells (SECs), leading to recruitment and activation of Kupffer cells, platelets and microcirculatory impairment. We investigated whether injured SECs and other cell types release microparticles during post-ischemic reperfusion, and whether such microparticles have pro-inflammatory, plateletactivating and pro-injurious effects that could contribute to IRI pathogenesis.

Methods: C57BL6 mice underwent 60 min of partial hepatic ischemia followed by 15 min-24 hrs of reperfusion. We collected blood and liver samples, isolated circulating microparticles, and determined protein and lipid content. To establish mechanism for microparticle production, we subjected murine primary hepatocytes to hypoxia-reoxygenation. Because microparticles express everted phosphatidylserine residues that are the target of annexin V, we analyzed the effects of an annexin V-homodimer (Diannexin or ASP8597) on post-ischemia microparticle production and function.

Results: Microparticles were detected in the circulation 15-30 min after post-ischemic reperfusion, and contained markers of SECs, platelets, natural killer T cells, and CD8+ cells; 4 hrs later, they contained markers of macrophages. Microparticles contained F2-isoprostanes, indicating oxidative damage to membrane lipids. Injection of mice with TNF-a increased microparticle formation, whereas Diannexin substantially reduced microparticle release and prevented IRI. Hypoxia-reoxygenation generated microparticles from primary hepatocytes by processes that involved oxidative stress. Exposing cultured hepatocytes to preparations of microparticles isolated from the circulation during IRI caused injury involving mitochondrial membrane permeability transition. Microparticles also activated platelets and induced neutrophil migration in vitro . The inflammatory properties of microparticles involved activation of NF-κB and JNK, increased expression of Eselectin, P-selectin, ICAM-1 and VCAM-1. All these processes were blocked by coating microparticles with Diannexin.

Conclusions: Following hepatic IRI, microparticles circulate and can be taken up by hepatocytes, where they activate signaling pathways that mediate inflammation and hepatocyte injury. Diannexin prevents microparticle formation and subsequent inflammation.

Original languageEnglish
Pages (from-to)e104376
JournalPLoS One
Issue number9
Publication statusPublished - 15 Sept 2014


Dive into the research topics of 'Microparticles mediate hepatic ischemia-reperfusion injury and are the targets of Diannexin (ASP8597)'. Together they form a unique fingerprint.

Cite this